XS004 Dasatinib (XS004) Improves Variability and Bioavailability in Humans Using Amorphous Solid Dispersion Formulation of Dasatinib with Potential Implications for Its Clinical Use
| Autor: | Lennernäs, Hans *, Liljebris, Charlotta *, Brisander, Magnus *, Jesson, Gérald *, Andersson, Per *, Larfors, Gunnar *, Stenke, Leif |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:9652-9653 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|